Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
PLoS One ; 18(5): e0286255, 2023.
Article in English | MEDLINE | ID: mdl-37228098

ABSTRACT

Betanin is a red pigment of red beetroot (Beta vulgaris L.), providing the beneficial effects to maintain human health. Betanin is involved in the characteristic red color of red beetroot, and used as an edible dye. Betanin is known to be a highly unstable pigment, and water solutions of betanin are nearly fully degraded after heating at 99°C for 60 min in the experimental conditions of this study. The present study investigated the effects of red beetroot juice (RBJ) and betanin on immune cells, and found that stimulation with RBJ and betanin induces interleukin (IL)-1ß, IL-8, and IL-10 mRNA in a human monocyte derived cell line, THP-1 cells. This mRNA induction after stimulation with RBJ and betanin was not significantly changed after heat treatment when attempting to induce degradation of the betanin. Following these results, the effects of heat degradation of betanin on the inhibition of lipopolysaccharide (LPS) induced nitric oxide (NO) production in RAW264 cells and the antioxidant capacity were investigated. The results showed that the inhibition activity of RBJ and betanin with the LPS induced NO production is not altered after heat degradation of betanin. In addition, the results of FRAP (ferric reducing antioxidant power) and DPPH (1,1-Diphenyl-2-picrylhydrazyl) assays indicate that a not inconsiderable degree of the antioxidant capacity of RBJ and betanin remained after heat degradation of betanin. These results suggest that it is important to consider the effects of degradation products of betanin in the evaluation of the beneficial effects of red beetroot on health.


Subject(s)
Antioxidants , Beta vulgaris , Humans , Antioxidants/pharmacology , Hot Temperature , Lipopolysaccharides/pharmacology , Betacyanins/pharmacology , Nitric Oxide
2.
PLoS One ; 18(4): e0284343, 2023.
Article in English | MEDLINE | ID: mdl-37053208

ABSTRACT

Chondroitin sulfate (CS) is a glycosaminoglycan, and CS derived from various animal species is used in drugs and food supplements to alleviate arthralgia. The CS is a high molecular weight compound, and hydrolysis of CS by intestinal microbiota is thought to be required for absorption in mammalians. Chondroitin sulfate oligosaccharides (Oligo-CS) are produced by hydrolysis with subcritical water from CS isolated from a species of skate, Raja pulchra for the improvement of bioavailability. The present study conducted in vitro experiments using murine cell lines, to compare the biological activities of Oligo-CS and high molecular weight CS composed with the similar disaccharide isomer units of D-glucuronic acid and N-acetyl-D-glucosamine (CS-C). The results show that Oligo-CS inhibits osteoclast differentiation of RAW264 cells significantly at lower concentrations than in CS. The cell viability of a myoblast cell line, C2C12 cells, was increased when the cells were grown in a differentiated medium for myotubes with Oligo-CS, where there were no effects on the cell viability in CS. These results suggest that in vitro Oligo-CS exhibits stronger bioactivity than high-molecular weight CS.


Subject(s)
Chondroitin Sulfates , Osteoclasts , Mice , Animals , Chondroitin Sulfates/pharmacology , Chondroitin Sulfates/metabolism , Osteoclasts/metabolism , Oligosaccharides/pharmacology , Cell Differentiation , Muscle Fibers, Skeletal/metabolism , Mammals/metabolism
3.
J Therm Biol ; 110: 103387, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36462849

ABSTRACT

Arboreal herbivores require large digestive tracts for leaf fermentation and detoxification; however, they must also have a low body mass that allows them to reach the foliage. The three-toed sloth, Bradypus tridactylus, experiences this trade-off, as leaves comprise 97.2% of its diet. Their calorie intake is extremely low owing to the low available caloric density of leaves and slow digestive processes related to leaf fibre fermentation and secondary compound detoxification. Sloths may require a high body temperature to assist fermentation; however, thermogenesis is energy-consuming. To investigate how sloths accomplish thermoregulation using marginal energy, we attached heart rate (HR) and temperature loggers to wild B. tridactylus individuals inhabiting the Amazon rainforest and recorded their HR and body surface temperature (Tskin). Tskin changed with ambient temperature (Ta) but was higher than Ta in 99.2% of cases. Increases in Tskin and HR did not coincide, suggesting that the increases were not caused by thermogenesis. Instead, they may passively increase Tskin by selecting warmer microhabitats and sunbathing. Consequently, 90.5% of Tskin were within 27.6-36.0 °C while the Ta fluctuated between 21.5 and 42.9 °C. This low-cost thermoregulation results in a low HR. In this study, the mean HR during observation was approximately 38.4% of the expected value based on the mammalian allometric relationship between body mass and HR. Thus, these properties may contribute to the low metabolic rates of sloths, alleviating their restricted energy intake.


Subject(s)
Sloths , Animals , Humans , Temperature , Heart Rate , Body Temperature Regulation , Thermogenesis
4.
ACS Omega ; 7(23): 19216-19224, 2022 Jun 14.
Article in English | MEDLINE | ID: mdl-35721936

ABSTRACT

One strategy to improve the performance of electric double-layer capacitors (EDLCs) is changing the current collector material. In this study, a three-dimensional porous current collector comprising stainless-steel fibers is fabricated using a relatively simple method. Capacitor properties of the EDLC using this unique current collector are characterized by cyclic voltammetry and charge-discharge tests. The voltammograms of the EDLC develop a more butterfly shape and an increased specific capacity at higher electrolyte concentrations. It shows reversible charge-discharge potential profiles, little capacity degradation (∼98% of the initial capacity at 1000th cycle), and a good rate performance at higher electrolyte concentrations (90% capacity retention for 2.5 times increase in discharge current). Its capacitance values (95-99 F g-1) are roughly twice the specific capacitance of an EDLC using the flat stainless-steel plate current collector (51 F g-1) without any performance degradation even at a higher loading of electrode active materials. Based on the AC impedance analysis, these good properties are attributed to the reduction in several resistances compared to the case of a flat stainless-steel plate: (i) the contact resistance between the electrode active material and the current collector, (ii) the resistance of the electrolyte in the finely branched space formed by the fibers and the active material, and (iii) the resistance in the diffusion layer. Increasing the electrolyte concentration further reduces the latter two resistances and the bulk electrolyte resistance, resulting in higher performance of the EDLC using the stainless-steel fiber sheet current collector.

5.
J Diabetes Investig ; 13(8): 1339-1346, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35389565

ABSTRACT

AIMS/INTRODUCTION: In older patients, the management of diabetic macular edema (DME) can be complicated by comorbidities, geriatric syndrome, and socioeconomic status. This study aims to evaluate the effects of aging on the management of DME. MATERIALS AND METHODS: This is a real-world clinical study including 1,552 patients with treatment-naïve center-involved DME. The patients were categorized into 4 categories by age at baseline (C1, <55; C2, 55-64; C3, 65-74; and C4, ≥75 years). The outcomes were the change in logarithm of the minimum angle of resolution best-corrected visual acuity (logMAR BCVA) and central retinal thickness (CRT), and the number of treatments from baseline to 2 years. RESULTS: From baseline to 2 years, the mean changes in logMAR BCVA from baseline to 2 years were -0.01 in C1, -0.06 in C2, -0.07 in C3, and 0.01 in C4 (P = 0.016), and the mean changes in CRT were -136.2 µm in C1, -108.8 µm in C2, -100.6 µm in C3, and -89.5 µm in C4 (P = 0.008). Treatments applied in the 2 year period exhibited decreasing trends with increasing age category on the number of intravitreal injections of anti-VEGF agents (P = 0.06), selecting local corticosteroid injection (P = 0.031), vitrectomy (P < 0.001), and laser photocoagulation outside the great vascular arcade (P < 0.001). CONCLUSIONS: Compared with younger patients with DME, patients with DME aged ≥75 years showed less frequent treatment, a lower BCVA gain, and a smaller CRT decrease. The management and visual outcome in older patients with DME would be unsatisfactory in real-world clinical practice.


Subject(s)
Diabetes Mellitus , Diabetic Retinopathy , Macular Edema , Aged , Aging , Diabetic Retinopathy/complications , Diabetic Retinopathy/epidemiology , Diabetic Retinopathy/therapy , Humans , Macular Edema/drug therapy , Macular Edema/therapy , Retrospective Studies , Treatment Outcome , Visual Acuity
6.
J Ophthalmol ; 2021: 2963822, 2021.
Article in English | MEDLINE | ID: mdl-34765261

ABSTRACT

PURPOSE: To study long-term clinical outcomes in patients with submacular hemorrhage (SMH) and/or vitreous hemorrhage (VH) associated with neovascular age-related macular degeneration (nAMD) and the real-world clinical situation of adding anti-VEGF therapy after pars plana vitrectomy (PPV). METHODS: In this retrospective case series, 25 eyes with SMH and/or VH associated with nAMD were treated by PPV and followed up for at least 24 months. When exudative changes were unresolved or recurred after PPV, additional intravitreal anti-VEGF therapy was given. RESULTS: The reasons for performing PPV were SMH (8 eyes) and VH (17 eyes) associated with nAMD. Mean best-corrected visual acuity (BCVA) of eyes with SMH improved significantly at 6 months (P < 0.01) and 12 months (P < 0.05) after PPV. Mean BCVA of eyes with VH improved at 1, 3, 6, 12, 18, and 24 months (P < 0.01) and at the final visit (P < 0.05). Post-PPV anti-VEGF therapy was initiated in 6 of 8 (75.0%) eyes with SMH and 7 of 17 (47.1%) eyes with VH. Of the 13 eyes given anti-VEGF therapy after PPV, 11 eyes had anti-VEGF therapy initiated within 10 months after surgery. Dry macula rate after PPV was 50.0% in SMH and 70.6% in VH. CONCLUSIONS: BCVA improved in eyes with SMH at 6 and 12 months after PPV, and the BCVA was maintained until the end of the study. BCVA improved significantly in eyes with VH at all time points after PPV. In eyes undergoing PPV for nAMD, recurrence of exudative changes after 11 months from the initial PPV was rare.

7.
Heliyon ; 6(12): e05505, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33336091

ABSTRACT

The Japanese larch, (Larix kaempferi) is known to contain abundant taxifolin (dihydroquercetin) in its xylem. In this study, to assess the bioactivities of taxifolin rich methanol extract of L. kaempferi (LK-ME), anti-inflammatory effect, and the anti-lipid accumulation effect of LK-ME were investigated. The results showed that nitric oxide (NO) and reactive oxygen species (ROS) were reduced after treatment with LK-ME, and that lipid accumulation in adipocyte differentiated 3T3-L1 cells was inhibited after the cells were grown in medium containing LK-ME. Taxifolin, the major compound contained in LK-ME, and its related compounds, quercetin and luteolin also exhibited similar effects with LK-ME. The LK-ME exhibits relatively strong anti-inflammatory and anti-lipid accumulation activities compared with that of similar amounts of taxifolin contained in LK-ME, suggesting that other minor compounds contained in LK-ME is involved in the effects. These results indicate the potential of taxifolin-rich L. kaempferi extract for use as a supplement to prevent excess inflammation and obesity.

8.
Br J Ophthalmol ; 104(12): 1755-1761, 2020 12.
Article in English | MEDLINE | ID: mdl-32169861

ABSTRACT

BACKGROUND/AIMS: To investigate the yearly change of real-world outcomes for best corrected visual acuity (BCVA) after 2-year clinical intervention for treatment-naïve diabetic macular oedema (DMO). METHODS: Retrospective analysis of aggregated, longitudinal medical records obtained from 27 retina specialised institutions in Japan from Survey of Treatment for DMO database. A total of 2049 treatment-naïve centre involving DMO eyes of which the initial intervention started between 2010 and 2015, and had been followed for 2 years, were eligible. As interventions, antivascular endothelial growth factor (VEGF) agents, local corticosteroids, macular photocoagulation and vitrectomy were defined. In each eye, baseline and final BCVA, the number of each intervention for 2 years was extracted. Each eye was classified by starting year of interventional treatment. RESULTS: Although baseline BCVA did not change by year, 2-year improvement of BCVA had been increased, and reached to +6.5 letters in the latest term. There is little difference among starting year about proportions of eyes which BCVA gained >15 letters, in contrast to those which lost >15 letters were decreased by year. The proportion of eyes receiving anti-VEGF therapy was dramatically increased, while those receiving the other therapies were gradually decreased. The proportion of eyes which maintained socially good vision of BCVA>20/40 has been increased and reached to 59.0% in the latest term. CONCLUSION: For recent years, treatment patterns for DMO have been gradually but certainly changed; as a result, better visual gain, suppression of worsened eyes and better final BCVA have been obtained. Anti-VEGF therapy has become the first-line therapy and its injection frequency has been increasing.


Subject(s)
Bevacizumab/administration & dosage , Diabetic Retinopathy/complications , Laser Coagulation/methods , Macular Edema/therapy , Ranibizumab/administration & dosage , Visual Acuity , Angiogenesis Inhibitors/administration & dosage , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/therapy , Female , Follow-Up Studies , Humans , Intravitreal Injections , Macular Edema/diagnosis , Macular Edema/etiology , Male , Middle Aged , Retrospective Studies , Time Factors , Treatment Outcome , Vascular Endothelial Growth Factor A/antagonists & inhibitors
9.
Ocul Immunol Inflamm ; 28(4): 552-555, 2020 May 18.
Article in English | MEDLINE | ID: mdl-31268776

ABSTRACT

PURPOSE: To present a case of necrotizing retinitis with Epstein-Barr virus (EBV)-positive ocular fluid in a patient with sudden unilateral vision loss, which was successfully treated with intravitreal methotrexate (MTX) injections. METHODS: Retrospective case report. RESULTS: An 83-year-old female who had been on methylprednisolone for 20 years due to interstitial pneumonia developed vitreous opacity and extensive necrotizing retinitis with retinal hemorrhage sparing the posterior pole in the left eye. Multiplex polymerase chain reaction (PCR) for viral DNA using vitreous sample was positive for EBV but negative for herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Real-time PCR detected EBV-DNA in aqueous humor but not in peripheral blood sample. Serologic testing was negative for Toxoplasma gondii, syphilis, and HIV. The patient did not respond to systemic ganciclovir or acyclovir. Subsequent treatment with intravitreal MTX resulted in immediate clinical improvement correlating with a decrease in copy number of EBV-DNA. CONCLUSION: Intravitreal MTX may be an effective treatment option for patients with necrotizing retinitis and EBV-positive ocular fluid not responding to conventional antiviral therapy.


Subject(s)
Aqueous Humor/virology , Epstein-Barr Virus Infections/drug therapy , Eye Infections, Viral/drug therapy , Herpesvirus 4, Human/genetics , Methotrexate/administration & dosage , Necrosis/drug therapy , Retinitis/drug therapy , Aged, 80 and over , DNA, Viral/analysis , Epstein-Barr Virus Infections/virology , Eye Infections, Viral/diagnosis , Eye Infections, Viral/virology , Female , Follow-Up Studies , Humans , Intravitreal Injections , Necrosis/diagnosis , Necrosis/virology , Nucleic Acid Synthesis Inhibitors/administration & dosage , Retinitis/diagnosis , Retinitis/virology , Retrospective Studies , Treatment Outcome
10.
Br J Ophthalmol ; 104(9): 1209-1215, 2020 09.
Article in English | MEDLINE | ID: mdl-31784500

ABSTRACT

BACKGROUND/AIMS: To investigate real-world outcomes for best-corrected visual acuity (BCVA) after 2-year clinical intervention for treatment-naïve, centr-involving diabetic macular oedema (DME). METHODS: Retrospective analysis of longitudinal medical records obtained from 27 institutions specialising in retinal diseases in Japan. A total of 2049 eyes with treatment-naïve DME commencing intervention between 2010 and 2015 who were followed for 2 years were eligible. Interventions for DME included anti-vascular endothelial growth factor (VEGF) therapy, local corticosteroid therapy, macular photocoagulation and vitrectomy. Baseline and final BCVA (logMAR) were assessed. Eyes were classified by the treatment pattern, depending on whether anti-VEGF therapy was used, into an anti-VEGF monotherapy group (group A), a combination therapy group (group B) and a group without anti-VEGF therapy (group C). RESULTS: The mean 2-year improvement of BCVA was -0.04±0.40 and final BCVA of >20/40 was obtained in 46.3% of eyes. Based on the treatment pattern, there were 427 eyes (20.9%) in group A, 807 eyes (39.4%) in group B and 815 eyes (39.8%) in group C. Mean improvement of BCVA was -0.09±0.39, -0.02±0.40 and -0.05±0.39, and the percentage of eyes with final BCVA of >20/40 was 49.4%, 38.9%, and 52.0%, respectively. CONCLUSION: Following 2-year real-world management of treatment-naïve DME in Japan, BCVA improved by 2 letters. Eyes treated by anti-VEGF monotherapy showed a better visual prognosis than eyes receiving combination therapy. Despite treatment for DME being selected by specialists in consideration of medical and social factors, a satisfactory visual prognosis was not obtained, but final BCVA remained >20/40 in half of all eyes.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Diabetic Retinopathy/therapy , Glucocorticoids/therapeutic use , Laser Coagulation , Macular Edema/therapy , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Visual Acuity/physiology , Vitrectomy , Aged , Bevacizumab/therapeutic use , Diabetic Retinopathy/drug therapy , Diabetic Retinopathy/physiopathology , Diabetic Retinopathy/surgery , Female , Follow-Up Studies , Humans , Intravitreal Injections , Japan , Macular Edema/drug therapy , Macular Edema/physiopathology , Macular Edema/surgery , Male , Middle Aged , Ranibizumab/therapeutic use , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Retrospective Studies
11.
Heliyon ; 5(7): e02047, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31338467

ABSTRACT

The larches, the Larix genus of plants are known as a natural source of taxifolin (dihydroquercetin), and extracts of its taxifolin rich xylem are used in dietary supplements to maintain health. In the present study, to assess biological activities of a methanol extract of the Japanese larch, Larix kaempferi (LK-ME), the effects of LK-ME on cell viability, inflammatory cytokine expression, and glycation were investigated. The effects of taxifolin which is known to be a main compound of LK-ME, and its related flavonoids, quercetin and luteolin were also examined. The results show that taxifolin exhibits lower growth inhibition activity and lesser induction activity of inflammatory cytokines in a human monocyte derived cell line, THP-1 cells, while in vitro anti-glycation activities of taxifolin were inhibiting at comparable levels to those of quercetin and luteolin. The growth inhibition and the cytokine induction activities, and the anti-glycation effects of LK-ME are assumed to have properties similar to taxifolin. The results of high performance liquid chromatography (HPLC) analysis indicated that taxifolin was detected as the main peak of LK-ME at the absorbance of 280 nm, and the concentration of taxifolin was measured as 3.12 mg/ml. The actual concentration of taxifolin in LK-ME is lower than the concentration estimated from the IC50 values calculated by the results of glycation assays, suggesting that other compounds contained in LK-ME are involved in the anti-glycation activity.

12.
J Biochem ; 163(1): 31-38, 2018 Jan 01.
Article in English | MEDLINE | ID: mdl-29036651

ABSTRACT

Several microbial molecules with pathogen-associated molecular patterns stimulate host innate immune responses. The innate immune system plays a crucial role in activating acquired immune response via cytokine production and antigen presentation. Previous studies have shown that Aureobasidium pullulans-cultured fluid (AP-CF), which contains ß-glucan, exhibits adjuvant activity and renders mice resistance to influenza A virus infection; however, the underlying mechanism remains elusive. In this study, we investigated the innate immune response to AP-CF. We found that intraperitoneal administration of AP-CF increased the serum level of IL-18 and the number of splenic IFN-γ producing CD4+ cells during influenza A virus infection. The adjuvant effect of AP-CF was distinct from that of alum, which is known to have the ability to stimulate a Th2 immune response. In addition, AP-CF injection barely increased the number of peritoneal neutrophils and inflammatory macrophages, whereas alum injection markedly increased the number of neutrophils and inflammatory macrophages, suggesting that AP-CF is a weak inducer of inflammation compared to alum. AP-CF induced IL-18 production by DC2.4 cells, a dendritic cell line, and by peritoneal exudate cells that include peritoneal macrophages. Collectively, our findings indicate that AP-CF is an adjuvant that promotes the Th1 response during influenza A virus infection.


Subject(s)
Ascomycota/chemistry , Glucans/pharmacology , Influenza A virus/drug effects , Interleukin-18/biosynthesis , Orthomyxoviridae Infections/drug therapy , Th1 Cells/drug effects , Animals , Glucans/chemistry , Male , Mice , Mice, Inbred C57BL , Microbial Sensitivity Tests , Th1 Cells/virology
14.
Elife ; 62017 08 01.
Article in English | MEDLINE | ID: mdl-28760201

ABSTRACT

SUV39H is the major histone H3 lysine 9 (H3K9)-specific methyltransferase that targets pericentric regions and is crucial for assembling silent heterochromatin. SUV39H recognizes trimethylated H3K9 (H3K9me3) via its chromodomain (CD), and enriched H3K9me3 allows SUV39H to target specific chromosomal regions. However, the detailed targeting mechanisms, especially for naïve chromatin without preexisting H3K9me3, are poorly understood. Here we show that Suv39h1's CD (Suv39h1-CD) binds nucleic acids, and this binding is important for its function in heterochromatin assembly. Suv39h1-CD had higher binding affinity for RNA than DNA, and its ability to bind nucleic acids was independent of its H3K9me3 recognition. Suv39h1 bound major satellite RNAs in vivo, and knockdown of major satellite RNAs lowered Suv39h1 retention on pericentromere. Suv39h1 mutational studies indicated that both the nucleic acid-binding and H3K9me-binding activities of Suv39h1-CD were crucial for its pericentric heterochromatin assembly. These results suggest that chromatin-bound RNAs contribute to creating SUV39H's target specificity.


Subject(s)
Heterochromatin/metabolism , Histones/metabolism , Methyltransferases/metabolism , Nucleic Acids/metabolism , Repressor Proteins/metabolism , Cell Line , Humans , Protein Binding
15.
Sci Rep ; 7(1): 2831, 2017 06 06.
Article in English | MEDLINE | ID: mdl-28588201

ABSTRACT

Black yeast, Aureobasidium pullulans is extracellularly produced ß-(1,3), (1,6)-D-glucan (ß-glucan) under certain conditions. In this study, using Glycine max cv. Kurosengoku (Kurosengoku soybeans), the production of ß-glucan through fermentation of A. pullulans was evaluated, and the effects of A. pullulans cultured fluid (AP-CF) containing ß-glucan made with Kurosengoku soybeans (kAP-CF) on a human monocyte derived cell line, Mono Mac 6 cells were investigated. Concentration of ß-glucan in kAP-CF reached the same level as normal AP-CF. An anti-angiogenic protein, Thrombospondin-1 (THBS1) was effectively induced after the stimulation with kAP-CF for comparison with AP-CF. The THBS1 is also induced after stimulation with hot water extract of Kurosengoku soybeans (KS-E), while the combined stimulation of ß-glucan with KS-E more effectively induced THBS1 than that with KS-E alone. These results suggest effects of A. pullulans-produced ß-glucan on the enhancement of Kurosengoku soybean-induced THBS1 expression.


Subject(s)
Ascomycota/metabolism , Gene Expression Regulation/drug effects , Glycine max/chemistry , Plant Extracts/pharmacology , Thrombospondin 1/genetics , beta-Glucans/pharmacology , Cell Line , Fermentation , Humans , Macrophage-1 Antigen/metabolism , Monocytes/drug effects , Monocytes/metabolism , RNA, Messenger/genetics
16.
Retina ; 37(3): 466-471, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28225722

ABSTRACT

PURPOSE: To evaluate the anatomical and functional outcome of the inverted internal limiting membrane (ILM) flap technique with vitrectomy for retinal detachment associated with macular hole (MHRD) in highly myopic eyes. METHODS: In this retrospective observational study, 21 eyes with MHRD that underwent vitrectomy with conventional ILM peeling (ILM-peeling group, n = 11) or the inverted ILM flap technique (ILM flap group, n = 10) combined with C3F8 tamponade were enrolled in this study. The initial retinal reattachment rate, macular hole closure rate, and postoperative visual acuity at the final visit were compared between the ILM-peeling group and ILM flap group. RESULTS: There was no significant difference in the retinal reattachment rate between ILM-peeling and ILM flap groups (91% and 100%, respectively). The macular hole closure rate in the ILM flap group was 80% (8 of 10 eyes), and was significantly higher than 36% (4 of 11 eyes) in the ILM-peeling group (P = 0.039). Among 12 eyes that achieved macular hole closure, there was no significant difference in median visual acuity after vitrectomy between the ILM flap group and ILM-peeling group (logMAR unit [Snellen acuity]: 1.0 [20/200] and 0.76 [20/125], respectively, P = 0.300). CONCLUSION: Compared with conventional ILM peeling, the inverted ILM flap technique was more effective for macular hole closure after vitrectomy for MHRD in myopic eye but showed no advantage in the postoperative visual outcome in this study.


Subject(s)
Epiretinal Membrane/surgery , Retinal Detachment/surgery , Retinal Perforations/surgery , Vitrectomy/methods , Adult , Aged , Basement Membrane/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Surgical Flaps , Tomography, Optical Coherence , Visual Acuity
17.
Retina ; 37(12): 2317-2325, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28098727

ABSTRACT

PURPOSE: The purpose of this study was to investigate whether vitreous levels of vascular endothelial growth factor (VEGF) predict late vitreous hemorrhage (VH) after vitrectomy for proliferative diabetic retinopathy, and how VEGF level changes in patients with postoperative late VH. METHODS: Eighty-five eyes of 68 patients with proliferative diabetic retinopathy who underwent vitrectomy were analyzed retrospectively. Vitreous samples were collected from eyes undergoing primary vitrectomy and from eyes with late VH undergoing second vitrectomy. Vitreous VEGF levels were measured using enzyme-linked immunosorbent assay. The relationship between VEGF level and late VH (>4 weeks) occurring during follow-up as well as clinical findings, and changes in VEGF level in eyes with late VH undergoing second vitrectomy were analyzed. RESULTS: Late VH occurred in 20 (24%) of 85 eyes, and 9 eyes required second vitrectomy. Vitreous levels of VEGF were significantly higher (median: 1,945 pg/mL; P < 0.0001) in eyes with late VH than in those without. Preexisting iris neovascularization (P < 0.0001), hypertension (P = 0.002), and proteinuria (P = 0.040) were also significant risk factors of late VH. Multivariate logistic regression analysis showed that a higher vitreous VEGF level was independently associated with a risk of postoperative late VH in patients with proliferative diabetic retinopathy (odds ratio: 20.8, 95% confidence interval: 2.72-159.47; P = 0.003). Vitreous VEGF level at second vitrectomy in patients with late VH was significantly lower compared with that at primary vitrectomy, but remained elevated (median: 1,610 pg/mL; P = 0.023). CONCLUSION: In patients with proliferative diabetic retinopathy, high intraocular VEGF level at primary vitrectomy was identified as an independent risk factor of postoperative late VH. Persistent overproduction of intraocular VEGF may be associated with postoperative late VH.


Subject(s)
Diabetic Retinopathy/surgery , Postoperative Hemorrhage/metabolism , Vascular Endothelial Growth Factor A/biosynthesis , Vitrectomy/adverse effects , Vitreoretinopathy, Proliferative/surgery , Vitreous Body/metabolism , Vitreous Hemorrhage/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , Diabetic Retinopathy/diagnosis , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Hemorrhage/diagnosis , Postoperative Hemorrhage/etiology , Prognosis , Retrospective Studies , Time Factors , Vitreoretinopathy, Proliferative/diagnosis , Vitreous Body/diagnostic imaging , Vitreous Hemorrhage/diagnosis , Vitreous Hemorrhage/etiology
18.
Cell Struct Funct ; 41(2): 145-152, 2016 Dec 03.
Article in English | MEDLINE | ID: mdl-27733730

ABSTRACT

Pericentric regions form epigenetically organized, silent heterochromatin structures that accumulate histone H3 lysine 9 tri-methylation (H3K9me3) and heterochromatin protein 1 (HP1), a methylated H3K9-binding protein. At pericentric regions, Suv39h is the major enzyme that generates H3K9me3. Suv39h also interacts directly with HP1. However, the importance of HP1 interaction for Suv39h-mediated H3K9me3 formation at the pericentromere is not well characterized. To address this question, we introduced HP1 binding-defective, N-terminally truncated mouse Suv39h1 (ΔN) into Suv39h-deficient cells. Pericentric H3K9me3-positive cells were not detected by endogenous-level expression of ΔN. Notably, ΔN could induce pericentric accumulation of H3K9me3 as wild type Suv39h1 did if it was overexpressed. These findings demonstrate that the N-terminal region of Suv39h1, presumably via HP1-Suv39h1 interaction, is required for Suv39h1-mediated pericentric H3K9me3 formation, but can be overridden if Suv39h1 is overproduced, indicating that Suv39h1-mediated heterochromatin formation is controlled by multiple modules, including HP1.


Subject(s)
Chromosomal Proteins, Non-Histone/metabolism , Histones/metabolism , Methyltransferases/metabolism , Repressor Proteins/metabolism , Animals , Blotting, Western , Chromobox Protein Homolog 5 , HEK293 Cells , Heterochromatin/metabolism , Humans , Methylation , Methyltransferases/chemistry , Methyltransferases/genetics , Mice , Microscopy, Fluorescence , Phenotype , Plasmids/genetics , Plasmids/metabolism , Protein Domains , Repressor Proteins/chemistry , Repressor Proteins/genetics
20.
J Reprod Dev ; 62(1): 121-5, 2016.
Article in English | MEDLINE | ID: mdl-26598326

ABSTRACT

Production of knockout mice using targeted embryonic stem cells (ESCs) is a powerful approach for investigating the function of specific genes in vivo. Although the protocol for gene targeting via homologous recombination (HR) in ESCs is already well established, the targeting efficiency varies at different target loci and is sometimes too low. It is known that knockdown of the Bloom syndrome gene, BLM, enhances HR-mediated gene targeting efficiencies in various cell lines. However, it has not yet been investigated whether this approach in ESCs is applicable for successful knockout mouse production. Therefore, we attempted to answer this question. Consistent with previous reports, Blm knockdown enhanced gene targeting efficiencies for three gene loci that we examined by 2.3-4.1-fold. Furthermore, the targeted ESC clones generated good chimeras and were successful in germline transmission. These data suggest that Blm knockdown provides a general benefit for efficient ESC-based and HR-mediated knockout mouse production.


Subject(s)
Embryonic Stem Cells/cytology , Gene Knockdown Techniques , RecQ Helicases/genetics , RecQ Helicases/physiology , Animals , DNA Helicases/genetics , Gene Targeting , Germ Cells/metabolism , Homologous Recombination , Karyotyping , Mice , Mice, Knockout , RNA Interference , RNA, Small Interfering/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...